April 01, 2014 - MM&M - Medical Marketing and Media

Print Issue: April 01, 2014

Are rep networks a solid resource?

Research shows HCPs bounce from site to site, so rep networks seem to offer both one-stop info shopping and industry contact. But do they provide quality interaction, or are they just a way to e-mail marketing materials?

Rare Diseases: Orphans in Danger

Rare Diseases: Orphans in Danger

For rare diseases and orphan products, the future looks promising, but as Peter Saltonstall finds, significant research, educational and policy challenges remain. A view from one of the patient community’s staunchest advocates

Therapeutic Focus 2014: Respiratory

Therapeutic Focus 2014: Respiratory

With generics firms taking aim at high-flying blockbusters, Big Pharma stalwarts in the asthma and COPD market are pinning their hopes for the future on a flurry of innovative biotech-developed assets. Noah Pines charts the rarefied air of the respiratory space

Speaker pay sharply cut: ProPublica

The approach of new transparency rules, coupled with patent losses and industry’s shift to specialty meds, has contributed to a big drop in the amount drugmakers are spending on promotional speaking, says ProPublica.

DTC Report: DTC Gets Smart

DTC Report 2014: DTC Gets Smart

Given the adoption of in-app video and gaming, forward-looking pharma marketers are experimenting with
so-called smart DTC on small screens — and the skeptics might not be able to stand in their way much longer.

ACCME defers a ban on logos again

ACCME defers a ban on logos again

The ACCME said its board decided, after a wave of feedback, to defer a ban on use of corporate logos in educational materials, disclosures and acknowledgement of commercial support. It’s the second time in three years that the ACCME board punted on the ban. The accreditor began accepting public comments on the proposed prohibition in…